Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

LAB

+ Watchlist+ Portfolio

Standard BioTools Inc.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.54
52-Week Range
$0.39 – $1.72
Market Cap
$225.03M
P/E (TTM)
—
EPS (TTM)
-0.09
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.40
PEG Ratio
—
Return on Equity
-7.79%
Return on Assets
-5.03%
Gross Margin
52.18%
Operating Margin
-55.98%
Profit Margin
157.62%
Current Ratio
9.75
Debt/Equity
0.05
Total Debt
$26.83M
Free Cash Flow
$179.64M
Revenue Growth
-0.90%
Earnings Growth
—
Enterprise Value
$-209.25M

Market Snapshot

About

Standard BioTools Inc. develops and commercializes technologies for life sciences research and clinical diagnostics. The company's platforms enable high-throughput genomics, proteomics, and single-cell analysis applications used in drug discovery, translational research, and precision medicine. Standard BioTools serves academic, government, pharmaceutical, biotechnology, and clinical laboratories with integrated systems and consumables for multi-omics analysis.